NO20013878D0 - (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme - Google Patents

(1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme

Info

Publication number: NO20013878D0
Authority: NO; Norway
Prior art keywords: phenacy; piperidylethyl; phenyl; preparation; pharmaceutical compositions
Prior art date: 1999-02-10

Application number

NO20013878A

Other languages

English (en)

Other versions

NO321149B1 (no

NO20013878L (no

Inventor

Jean Philippe Ducoux

Xavier Emonds-Alt

Patrick Gueule

Vincenzo Proietto

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-10

Filing date

2001-08-08

Publication date

2001-08-08

1999-02-10 Priority claimed from FR9901593A external-priority patent/FR2789389B3/fr

2001-08-08 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2001-08-08 Publication of NO20013878D0 publication Critical patent/NO20013878D0/no

2001-10-10 Publication of NO20013878L publication Critical patent/NO20013878L/no

2006-03-27 Publication of NO321149B1 publication Critical patent/NO321149B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20013878A 1999-02-10 2001-08-08 (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende de samme samt anvendelse NO321149B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9901593A FR2789389B3 (fr)	1999-02-10	1999-02-10	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR9904429A FR2789390B3 (fr)	1999-02-10	1999-04-07	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
PCT/FR2000/000284 WO2000047572A1 (fr)	1999-02-10	2000-02-08	Derives de (1-phenacy-3-phenyl-3-piperidylethyl)piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (3)

Publication Number	Publication Date
NO20013878D0 true NO20013878D0 (no)	2001-08-08
NO20013878L NO20013878L (no)	2001-10-10
NO321149B1 NO321149B1 (no)	2006-03-27

Family

ID=26234812

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20013878A NO321149B1 (no)	1999-02-10	2001-08-08	(1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende de samme samt anvendelse
NO20051958A NO20051958L (no)	1999-02-10	2005-04-21	Forbindelser

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20051958A NO20051958L (no)	1999-02-10	2005-04-21	Forbindelser

Country Status (36)

Country	Link
US (2)	US6642233B1 (no)
EP (1)	EP1150970B1 (no)
JP (1)	JP4648544B2 (no)
KR (1)	KR100611261B1 (no)
CN (1)	CN1273463C (no)
AR (1)	AR028813A1 (no)
AT (1)	ATE370942T1 (no)
AU (1)	AU763716B2 (no)
BG (1)	BG65031B1 (no)
BR (1)	BR0008067A (no)
CA (1)	CA2360894C (no)
CO (1)	CO4980896A1 (no)
CZ (1)	CZ300765B6 (no)
DE (1)	DE60036081T2 (no)
DK (1)	DK1150970T3 (no)
EE (1)	EE04437B1 (no)
ES (1)	ES2291187T3 (no)
FR (1)	FR2789390B3 (no)
HR (1)	HRP20010566A2 (no)
HU (1)	HUP0201281A3 (no)
ID (1)	ID29219A (no)
IL (2)	IL144363A0 (no)
ME (1)	MEP11908A (no)
NO (2)	NO321149B1 (no)
NZ (1)	NZ513053A (no)
PE (1)	PE20001463A1 (no)
PL (1)	PL198561B1 (no)
PT (1)	PT1150970E (no)
RS (1)	RS50210B (no)
RU (1)	RU2220956C2 (no)
SI (1)	SI1150970T1 (no)
SK (1)	SK286401B6 (no)
TR (1)	TR200102331T2 (no)
TW (1)	TWI254712B (no)
UA (1)	UA70986C2 (no)
WO (1)	WO2000047572A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003070745A2 (en) *	2002-02-20	2003-08-28	Sepracor Inc.	Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en)	2002-02-20	2005-01-13	Sepracor Inc.	Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
WO2005082419A1 (en) *	2004-01-30	2005-09-09	Pfizer Products Inc.	Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
FR2873373B1 (fr) *	2004-07-23	2006-09-08	Sanofi Synthelabo	Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
GB2452696B (en) *	2007-08-02	2009-09-23	Cambridge Entpr Ltd	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
DE102008015426A1 (de) *	2008-03-20	2009-09-24	Beiersdorf Ag	Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
DE102008015425A1 (de) *	2008-03-20	2010-01-21	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015428A1 (de) *	2008-03-20	2009-09-24	Beiersdorf Ag	Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US512901A (en) *		1894-01-16		Folding bed
GB821012A (en) *	1957-01-15	1959-09-30	Rhone Poulenc Sa	New phenthiazine derivatives and processes for their preparation
FR2676055B1 (fr)	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
MY110227A (en) *	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
HU221434B (en) *	1994-08-25	2002-10-28	Merrell Pharma Inc	Substituted piperidines, pharmaceutical compositions containing them and their use
EP0714891A1 (en) *	1994-11-22	1996-06-05	Eli Lilly And Company	Heterocyclic tachykinin receptor antagonists

1999
- 1999-04-07 FR FR9904429A patent/FR2789390B3/fr not_active Expired - Lifetime
2000
- 2000-02-08 US US09/913,106 patent/US6642233B1/en not_active Expired - Fee Related
- 2000-02-08 NZ NZ513053A patent/NZ513053A/xx not_active IP Right Cessation
- 2000-02-08 IL IL14436300A patent/IL144363A0/xx not_active IP Right Cessation
- 2000-02-08 PL PL350243A patent/PL198561B1/pl not_active IP Right Cessation
- 2000-02-08 ES ES00903744T patent/ES2291187T3/es not_active Expired - Lifetime
- 2000-02-08 KR KR1020017009983A patent/KR100611261B1/ko not_active Expired - Fee Related
- 2000-02-08 RU RU2001121989/04A patent/RU2220956C2/ru not_active IP Right Cessation
- 2000-02-08 RS YUP-564/01A patent/RS50210B/sr unknown
- 2000-02-08 UA UA2001075184A patent/UA70986C2/uk unknown
- 2000-02-08 CZ CZ20012888A patent/CZ300765B6/cs not_active IP Right Cessation
- 2000-02-08 EE EEP200100417A patent/EE04437B1/xx not_active IP Right Cessation
- 2000-02-08 AT AT00903744T patent/ATE370942T1/de not_active IP Right Cessation
- 2000-02-08 SI SI200030968T patent/SI1150970T1/sl unknown
- 2000-02-08 JP JP2000598492A patent/JP4648544B2/ja not_active Expired - Fee Related
- 2000-02-08 WO PCT/FR2000/000284 patent/WO2000047572A1/fr not_active Ceased
- 2000-02-08 TR TR2001/02331T patent/TR200102331T2/xx unknown
- 2000-02-08 EP EP00903744A patent/EP1150970B1/fr not_active Expired - Lifetime
- 2000-02-08 PT PT00903744T patent/PT1150970E/pt unknown
- 2000-02-08 HR HR20010566A patent/HRP20010566A2/hr not_active Application Discontinuation
- 2000-02-08 CN CNB008058261A patent/CN1273463C/zh not_active Expired - Fee Related
- 2000-02-08 BR BR0008067-5A patent/BR0008067A/pt not_active Application Discontinuation
- 2000-02-08 CA CA002360894A patent/CA2360894C/en not_active Expired - Fee Related
- 2000-02-08 SK SK1139-2001A patent/SK286401B6/sk not_active IP Right Cessation
- 2000-02-08 HU HU0201281A patent/HUP0201281A3/hu unknown
- 2000-02-08 DK DK00903744T patent/DK1150970T3/da active
- 2000-02-08 ID IDW00200101651A patent/ID29219A/id unknown
- 2000-02-08 DE DE60036081T patent/DE60036081T2/de not_active Expired - Lifetime
- 2000-02-08 ME MEP-119/08A patent/MEP11908A/xx unknown
- 2000-02-08 AU AU25531/00A patent/AU763716B2/en not_active Ceased
- 2000-02-09 TW TW089102106A patent/TWI254712B/zh active
- 2000-02-09 AR ARP000100555A patent/AR028813A1/es active IP Right Grant
- 2000-02-10 PE PE2000000102A patent/PE20001463A1/es not_active Application Discontinuation
- 2000-02-10 CO CO00008757A patent/CO4980896A1/es unknown
2001
- 2001-08-08 BG BG105794A patent/BG65031B1/bg unknown
- 2001-08-08 NO NO20013878A patent/NO321149B1/no not_active IP Right Cessation
2003
- 2003-09-16 US US10/663,124 patent/US6951940B2/en not_active Expired - Fee Related
2005
- 2005-04-21 NO NO20051958A patent/NO20051958L/no unknown
2007
- 2007-01-07 IL IL180579A patent/IL180579A0/en unknown

Also Published As

Publication number	Publication date
UA70986C2 (uk)	2004-11-15
CZ300765B6 (cs)	2009-08-05
WO2000047572A1 (fr)	2000-08-17
NO321149B1 (no)	2006-03-27
JP4648544B2 (ja)	2011-03-09
DK1150970T3 (da)	2007-12-17
CN1345317A (zh)	2002-04-17
JP2002536442A (ja)	2002-10-29
BG105794A (en)	2002-05-31
AR028813A1 (es)	2003-05-28
EE200100417A (et)	2002-12-16
FR2789390A1 (fr)	2000-08-11
US20040072840A1 (en)	2004-04-15
TR200102331T2 (tr)	2002-03-21
NO20051958L (no)	2001-10-10
KR100611261B1 (ko)	2006-08-10
ES2291187T3 (es)	2008-03-01
DE60036081D1 (de)	2007-10-04
ATE370942T1 (de)	2007-09-15
PT1150970E (pt)	2007-11-07
RS50210B (sr)	2009-07-15
CO4980896A1 (es)	2000-11-27
SK286401B6 (sk)	2008-09-05
US6642233B1 (en)	2003-11-04
PE20001463A1 (es)	2001-02-21
NZ513053A (en)	2002-10-25
US6951940B2 (en)	2005-10-04
BG65031B1 (bg)	2006-12-29
YU56401A (sh)	2004-03-12
IL144363A0 (en)	2002-05-23
BR0008067A (pt)	2001-11-06
AU2553100A (en)	2000-08-29
EP1150970B1 (fr)	2007-08-22
IL180579A0 (en)	2007-06-03
TWI254712B (en)	2006-05-11
HUP0201281A3 (en)	2003-05-28
CZ20012888A3 (cs)	2001-11-14
EP1150970A1 (fr)	2001-11-07
KR20010101818A (ko)	2001-11-14
MEP11908A (en)	2010-06-10
CA2360894C (en)	2009-09-22
PL350243A1 (en)	2002-12-02
CA2360894A1 (en)	2000-08-17
DE60036081T2 (de)	2008-05-15
FR2789390B3 (fr)	2001-03-09
HUP0201281A2 (en)	2002-09-28
RU2220956C2 (ru)	2004-01-10
EE04437B1 (et)	2005-02-15
HK1038927A1 (en)	2002-04-04
ID29219A (id)	2001-08-16
AU763716B2 (en)	2003-07-31
PL198561B1 (pl)	2008-06-30
NO20013878L (no)	2001-10-10
SK11392001A3 (sk)	2002-02-05
SI1150970T1 (sl)	2008-02-29
CN1273463C (zh)	2006-09-06
HRP20010566A2 (en)	2002-08-31

Publication	Publication Date	Title
NO20001409L (no)	2000-05-16	Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
HUP0204515A3 (en)	2005-04-28	4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203316A3 (en)	2004-07-28	Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
NO20016038D0 (no)	2001-12-10	Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
HUP0204245A3 (en)	2004-12-28	Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300618A3 (en)	2003-12-29	Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0000748A3 (en)	2003-12-29	4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0202731A3 (en)	2003-10-28	O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201516A3 (en)	2003-03-28	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en)	2004-12-28	Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en)	2003-03-28	Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0303118A3 (en)	2007-08-28	Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0203184A3 (en)	2004-12-28	Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL180579A0 (en)	2007-06-03	Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
PL356911A1 (en)	2004-07-12	Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
HUP0105479A3 (en)	2002-06-28	Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0201315A3 (en)	2003-02-28	4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204001A3 (en)	2005-04-28	Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en)	2007-03-28	Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0101234A3 (en)	2002-12-28	Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0201916A3 (en)	2003-05-28	Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
NO20014803D0 (no)	2001-10-03	Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
HUP0201797A3 (en)	2003-03-28	3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL154986A0 (en)	2003-10-31	Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof

Legal Events

Date	Code	Title	Description
2012-10-01	MM1K	Lapsed by not paying the annual fees